Nanoparticle Contract Manufacturing Services Industry to Generate Revenues of $3.2 Billion by 2029: Uncover the Leading Trends and Opportunities During 2024-2029
13 déc. 2024 07h15 HE
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Nanoparticle Contract Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added...
Asia Pacific Biopharma Excipients Market Research Report 2024-2030: Patent Expiry of Blockbuster Biologics such as Erbitux, Rituxan, Herceptin, Avastin, Aranesp, and Enbrel Fueling Investments
19 nov. 2024 11h28 HE
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Biopharma Excipients Market Size, Share and Trends Analysis Report by Product (Solubilizers & Surfactants/Emulsifiers, Polyols,...
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
14 oct. 2024 11h15 HE
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
Lipid Nanoparticles Market Research 2024 - Global Forecast to 2029: Increasing Use of Lipid Nanoparticles in Anti-Cancer Research and Growing Demand for Advanced Drug Delivery Systems
07 oct. 2024 11h52 HE
|
Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Lipid Nanoparticles Market by Product (Ionizable Lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (SiRNA, MRNA), Application,...
Lipid Nanoparticles for Gene Therapy Market Research 2024: Gene Therapy Sales are Projected to Exceed $10bn by 2027 - LNPs have Gained Popularity as Carriers for Gene Therapies
18 sept. 2024 09h05 HE
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Gene therapy - Lipid nanoparticles" report has been added to ResearchAndMarkets.com's offering.This report discusses the developing trend and...
Polymeric Nanoparticles Strategic Business Report 2023-2024 & 2030 - Growing Interest in Non-Toxic and Biodegradable Nanoparticles Bodes Well for Market Growth
17 sept. 2024 07h44 HE
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Polymeric Nanoparticles - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymeric...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
10 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
Polymer Nanocomposites Strategic Business Report 2024-2030: Revolutionizing Material Science with Nano-Innovations
06 sept. 2024 07h27 HE
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Polymer Nanocomposites - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Polymer...
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
05 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate